Technical Analysis for ARPO - Aerpio Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade F 0.6499 -8.45% -0.0600
ARPO closed down 8.45 percent on Friday, September 27, 2019, on 79 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical ARPO trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Hammer Candlestick Bullish -8.45%

Older signals for ARPO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company is headquartered in Cincinnati, Ohio. Aerpio Pharmaceuticals, Inc.(OTCPK:ARPO) operates independently of Akebia Therapeutics, Inc. as of December 22, 2011.
Biotechnology Pharmaceutical Industry Biopharmaceutical Life Sciences Pharmacy Alpha Monoclonal Antibodies Diabetic Retinopathy Inflammatory Bowel Disease Retinopathy Treatment Of Inflammatory Bowel Disease
Is ARPO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.75
52 Week Low 0.6499
Average Volume 43,838
200-Day Moving Average 0.0
50-Day Moving Average 3.5323
20-Day Moving Average 3.1577
10-Day Moving Average 2.3455
Average True Range 0.5755
ADX 29.08
+DI 26.882
-DI 53.2801
Chandelier Exit (Long, 3 ATRs ) 3.2235
Chandelier Exit (Short, 3 ATRs ) 2.3764
Upper Bollinger Band 5.5798
Lower Bollinger Band 0.7356
Percent B (%b) -0.02
BandWidth 153.409127
MACD Line -0.6565
MACD Signal Line -0.3411
MACD Histogram -0.3154
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.7551
Resistance 3 (R3) 0.7667 0.7434 0.7375
Resistance 2 (R2) 0.7434 0.7166 0.7375 0.7317
Resistance 1 (R1) 0.6966 0.7000 0.6850 0.6850 0.7258
Pivot Point 0.6733 0.6733 0.6674 0.6674 0.6733
Support 1 (S1) 0.6265 0.6465 0.6149 0.6149 0.5740
Support 2 (S2) 0.6032 0.6299 0.5973 0.5681
Support 3 (S3) 0.5564 0.6032 0.5623
Support 4 (S4) 0.5448